These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 27874023)

  • 21. Efficacy of stimulants for psychiatric symptoms in individuals with traumatic brain injury.
    Maksimowski MB; Tampi RR
    Ann Clin Psychiatry; 2016 Aug; 28(3):156-66. PubMed ID: 27490831
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Therapeutic Efficacy of Environmental Enrichment and Methylphenidate Alone and in Combination after Controlled Cortical Impact Injury.
    Leary JB; Bondi CO; LaPorte MJ; Carlson LJ; Radabaugh HL; Cheng JP; Kline AE
    J Neurotrauma; 2017 Jan; 34(2):444-450. PubMed ID: 26972895
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immediate neurocognitive effects of methylphenidate on learning-impaired survivors of childhood cancer.
    Thompson SJ; Leigh L; Christensen R; Xiong X; Kun LE; Heideman RL; Reddick WE; Gajjar A; Merchant T; Pui CH; Hudson MM; Mulhern RK
    J Clin Oncol; 2001 Mar; 19(6):1802-8. PubMed ID: 11251012
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MLC901 (NeuroAiD II™) for cognition after traumatic brain injury: a pilot randomized clinical trial.
    Theadom A; Barker-Collo S; Jones KM; Parmar P; Bhattacharjee R; Feigin VL
    Eur J Neurol; 2018 Aug; 25(8):1055-e82. PubMed ID: 29611892
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Do effects of methylphenidate on cognitive performance last beyond treatment? A randomized placebo-controlled trial in boys and men with ADHD.
    Tamminga HGH; Reneman L; Schrantee A; Bottelier MA; Bouziane C; Geurts HM; Groenman AP
    Eur Neuropsychopharmacol; 2021 May; 46():1-13. PubMed ID: 33735707
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of methylphenidate on attention deficits after traumatic brain injury: a multidimensional, randomized, controlled trial.
    Whyte J; Hart T; Vaccaro M; Grieb-Neff P; Risser A; Polansky M; Coslett HB
    Am J Phys Med Rehabil; 2004 Jun; 83(6):401-20. PubMed ID: 15166683
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and Safety of HLD200, Delayed-Release and Extended-Release Methylphenidate, in Children with Attention-Deficit/Hyperactivity Disorder.
    Pliszka SR; Wilens TE; Bostrom S; Arnold VK; Marraffino A; Cutler AJ; López FA; DeSousa NJ; Sallee FR; Incledon B; Newcorn JH
    J Child Adolesc Psychopharmacol; 2017 Aug; 27(6):474-482. PubMed ID: 29172680
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A randomized, placebo-controlled trial of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder.
    Biederman J; Mick E; Surman C; Doyle R; Hammerness P; Harpold T; Dunkel S; Dougherty M; Aleardi M; Spencer T
    Biol Psychiatry; 2006 May; 59(9):829-35. PubMed ID: 16373066
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Methylphenidate on Cognitive Improvement in Patients with Traumatic Brain Injury: A Meta-Analysis.
    Huang CH; Huang CC; Sun CK; Lin GH; Hou WH
    Curr Neuropharmacol; 2016; 14(3):272-81. PubMed ID: 26951094
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Computerized Working Memory Training for Children with Moderate to Severe Traumatic Brain Injury: A Double-Blind, Randomized, Placebo-Controlled Trial.
    Phillips NL; Mandalis A; Benson S; Parry L; Epps A; Morrow A; Lah S
    J Neurotrauma; 2016 Dec; 33(23):2097-2104. PubMed ID: 27050628
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Traumatic brain injury-related attention deficits: treatment outcomes with lisdexamfetamine dimesylate (Vyvanse).
    Tramontana MG; Cowan RL; Zald D; Prokop JW; Guillamondegui O
    Brain Inj; 2014; 28(11):1461-72. PubMed ID: 24988121
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparing effects of methylphenidate, sertraline and placebo on neuropsychiatric sequelae in patients with traumatic brain injury.
    Lee H; Kim SW; Kim JM; Shin IS; Yang SJ; Yoon JS
    Hum Psychopharmacol; 2005 Mar; 20(2):97-104. PubMed ID: 15641125
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A head-to-head randomized clinical trial of methylphenidate and atomoxetine treatment for executive function in adults with attention-deficit hyperactivity disorder.
    Ni HC; Shang CY; Gau SS; Lin YJ; Huang HC; Yang LK
    Int J Neuropsychopharmacol; 2013 Oct; 16(9):1959-73. PubMed ID: 23672818
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Short-term efficacy of methylphenidate: a randomized, double-blind, placebo-controlled trial among survivors of childhood cancer.
    Mulhern RK; Khan RB; Kaplan S; Helton S; Christensen R; Bonner M; Brown R; Xiong X; Wu S; Gururangan S; Reddick WE
    J Clin Oncol; 2004 Dec; 22(23):4795-803. PubMed ID: 15570081
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effects of methylphenidate on cognitive function in children with attention-deficit/hyperactivity disorder.
    Kubas HA; Backenson EM; Wilcox G; Piercy JC; Hale JB
    Postgrad Med; 2012 Sep; 124(5):33-48. PubMed ID: 23095424
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neurocognitive effects of methylphenidate on ADHD children with different DAT genotypes: a longitudinal open label trial.
    Pasini A; Sinibaldi L; Paloscia C; Douzgou S; Pitzianti MB; Romeo E; Curatolo P; Pizzuti A
    Eur J Paediatr Neurol; 2013 Jul; 17(4):407-14. PubMed ID: 23541676
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A large, double-blind, randomized clinical trial of methylphenidate in the treatment of adults with attention-deficit/hyperactivity disorder.
    Spencer T; Biederman J; Wilens T; Doyle R; Surman C; Prince J; Mick E; Aleardi M; Herzig K; Faraone S
    Biol Psychiatry; 2005 Mar; 57(5):456-63. PubMed ID: 15737659
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enzogenol for cognitive functioning in traumatic brain injury: a pilot placebo-controlled RCT.
    Theadom A; Mahon S; Barker-Collo S; McPherson K; Rush E; Vandal AC; Feigin VL
    Eur J Neurol; 2013 Aug; 20(8):1135-44. PubMed ID: 23384428
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A phase III, double-blind, placebo-controlled prospective randomized clinical trial of d-threo-methylphenidate HCl in brain tumor patients receiving radiation therapy.
    Butler JM; Case LD; Atkins J; Frizzell B; Sanders G; Griffin P; Lesser G; McMullen K; McQuellon R; Naughton M; Rapp S; Stieber V; Shaw EG
    Int J Radiat Oncol Biol Phys; 2007 Dec; 69(5):1496-501. PubMed ID: 17869448
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cognitive rehabilitation post traumatic brain injury: A systematic review for emerging use of virtual reality technology.
    Alashram AR; Annino G; Padua E; Romagnoli C; Mercuri NB
    J Clin Neurosci; 2019 Aug; 66():209-219. PubMed ID: 31085075
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.